Arterial access site and outcomes in patients undergoing percutaneous coronary intervention with and without vorapaxar

ConclusionsTransradial access was associated with lower bleeding rates and similar long‐term ischemic outcomes, suggesting transradial access is safer than transfemoral access among ACS patients receiving potent antiplatelet therapies. Because of the nonrandomized allocation of arterial access, these results should be considered exploratory. © 2015 Wiley Periodicals, Inc.

http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fccd.26335

Source: Catheterization and Cardiovascular Interventions - December 23, 2015 Category: Cardiovascular & Thoracic Surgery Authors: Jean‐Pierre Déry, Kenneth W. Mahaffey, Pierluigi Tricoci, Harvey D. White, Mohua Podder, Cynthia M. Westerhout, David J. Moliterno, Robert A. Harrington, Edmond Chen, John Strony, Frans Van de Werf, Khaled M. Ziada, Claes Held, Philip E. Aylward, Paul Tags: Coronary Artery Disease Source Type: research